276 related articles for article (PubMed ID: 32590154)
21. Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation.
Liu W; Han X; Li Q; Sun L; Wang J
Biomed Pharmacother; 2022 Sep; 153():113460. PubMed ID: 36076570
[TBL] [Abstract][Full Text] [Related]
22. Iguratimod decreases bleomycin-induced pulmonary fibrosis in association with inhibition of TNF-α in mice.
Shao S; Qu Z; Liang Y; Xu Y; Zhou D; Li D; Zhang Y; Yin S
Int Immunopharmacol; 2021 Oct; 99():107936. PubMed ID: 34284287
[TBL] [Abstract][Full Text] [Related]
23. 2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-β signaling pathway.
Ikushima E; Ishikane S; Kishigami T; Matsunaga H; Igawa K; Tomooka K; Nishimura Y; Takahashi-Yanaga F
Biochem Pharmacol; 2022 Mar; 197():114950. PubMed ID: 35143754
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin attenuates pulmonary fibrosis in mice and human lung fibroblasts, by the regulation of myofibroblast differentiation and apoptosis.
Yildirim M; Kayalar O; Atahan E; Oztay F
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23074. PubMed ID: 35416377
[TBL] [Abstract][Full Text] [Related]
25. Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-β1/Smad pathway.
Zhou Y; Zhang Q; Gao Y; Tan M; Zheng R; Zhao L; Zhang X
Int J Mol Med; 2018 Jan; 41(1):473-484. PubMed ID: 29115383
[TBL] [Abstract][Full Text] [Related]
26. Lysocardiolipin acyltransferase regulates TGF-β mediated lung fibroblast differentiation.
Huang LS; Jiang P; Feghali-Bostwick C; Reddy SP; Garcia JGN; Natarajan V
Free Radic Biol Med; 2017 Nov; 112():162-173. PubMed ID: 28751023
[TBL] [Abstract][Full Text] [Related]
27. Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice.
Zhang L; Cheng T; Chen W; Zhong C; Li M; Xie Y; Deng Q; Wang H; Yang Z; Ju J; Liang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4153-4163. PubMed ID: 38032492
[TBL] [Abstract][Full Text] [Related]
28. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
29. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
30. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
31. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
Molagoda IMN; Sanjaya SS; Lee KT; Choi YH; Lee JH; Lee MH; Kang CH; Lee CM; Kim GY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108428
[TBL] [Abstract][Full Text] [Related]
32. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
34. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation.
Mou Y; Liu J; Pan T; Wang Q; Miao K; Xu Y; Xiong W; Yu J
Biomed Pharmacother; 2021 Jul; 139():111500. PubMed ID: 33901873
[TBL] [Abstract][Full Text] [Related]
36. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
37. Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways.
Yao F; Xu M; Dong L; Shen X; Shen Y; Jiang Y; Zhu T; Zhang C; Yu G
BMC Pulm Med; 2024 May; 24(1):229. PubMed ID: 38730387
[TBL] [Abstract][Full Text] [Related]
38. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
39. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
[TBL] [Abstract][Full Text] [Related]
40. Classical transient receptor potential 6 (TRPC6) channels support myofibroblast differentiation and development of experimental pulmonary fibrosis.
Hofmann K; Fiedler S; Vierkotten S; Weber J; Klee S; Jia J; Zwickenpflug W; Flockerzi V; Storch U; Yildirim AÖ; Gudermann T; Königshoff M; Dietrich A
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):560-568. PubMed ID: 27932059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
